Literature DB >> 1862161

Continuous performance tests in schizophrenic patients: stimulus and medication effects on performance.

E A Earle-Boyer1, M R Serper, M Davidson, P D Harvey.   

Abstract

Medicated (n = 17) and unmedicated (n = 17) schizophrenic patients were compared to a normal control group (n = 19) on their performance on auditory and visual versions of the Continuous Performance Test (CPT). Within each stimulus modality, performance was examined on lexical and nonlexical target stimuli. Neuromotor competence was assessed on the basis of motor speed and proficiency. Normal subjects made fewer errors of all types than schizophrenic patients. Unmedicated patients made significantly more errors on nonlexical stimuli than medicated patients, with medication status found not to be associated with stimulus modality effects. Motor proficiency was associated with CPT performance in the medicated patients, but not the unmedicated ones, although this difference in correlations did not account for the group differences between these patients. The authors discuss the implications of these data for the type of cognitive and attentional functions that are affected by medication in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1862161     DOI: 10.1016/0165-1781(91)90105-x

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  12 in total

1.  Differential attenuation of d-amphetamine-induced disruption of conditional discrimination performance by dopamine and serotonin antagonists.

Authors:  Michael J Dunn; Simon Killcross
Journal:  Psychopharmacology (Berl)       Date:  2006-08-30       Impact factor: 4.530

Review 2.  Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia.

Authors:  Nurith Amitai; Athina Markou
Journal:  Biol Psychiatry       Date:  2010-05-21       Impact factor: 13.382

3.  A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia.

Authors:  Mario Fioravanti; Olimpia Carlone; Barbara Vitale; Maria Elena Cinti; Linda Clare
Journal:  Neuropsychol Rev       Date:  2005-06       Impact factor: 7.444

4.  Impaired associative inference in patients with schizophrenia.

Authors:  Kristan Armstrong; Samet Kose; Lisa Williams; Austin Woolard; Stephan Heckers
Journal:  Schizophr Bull       Date:  2010-12-06       Impact factor: 9.306

5.  Attention and clinical symptoms in schizophrenia.

Authors:  B Cornblatt; M Obuchowski; D B Schnur; J D O'Brien
Journal:  Psychiatr Q       Date:  1997

6.  PCBs and measures of attention and impulsivity on a continuous performance task of young adults.

Authors:  Bita Behforooz; Joan Newman; Mia V Gallo; Lawrence M Schell
Journal:  Neurotoxicol Teratol       Date:  2017-09-04       Impact factor: 3.763

7.  Evaluation of the validity of the Psychology Experiment Building Language tests of vigilance, auditory memory, and decision making.

Authors:  Brian Piper; Shane T Mueller; Sara Talebzadeh; Min Jung Ki
Journal:  PeerJ       Date:  2016-03-15       Impact factor: 2.984

Review 8.  Theoretical Modeling of Cognitive Dysfunction in Schizophrenia by Means of Errors and Corresponding Brain Networks.

Authors:  Yuliya Zaytseva; Iveta Fajnerová; Boris Dvořáček; Eva Bourama; Ilektra Stamou; Kateřina Šulcová; Jiří Motýl; Jiří Horáček; Mabel Rodriguez; Filip Španiel
Journal:  Front Psychol       Date:  2018-07-03

Review 9.  Markers of vulnerability in schizophrenia.

Authors:  Maria Ladea; Dan Prelipceanu
Journal:  J Med Life       Date:  2009 Apr-Jun

10.  Measuring Attention in Rodents: Comparison of a Modified Signal Detection Task and the 5-Choice Serial Reaction Time Task.

Authors:  Karly M Turner; James Peak; Thomas H J Burne
Journal:  Front Behav Neurosci       Date:  2016-01-14       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.